Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
12/01/2009 | CA2157062C Chemiluminescent reagent and assay using a substituted acetanilide for light generation |
12/01/2009 | CA2107513C Fusion protein for prodrug activation |
11/28/2009 | CA2667102A1 Chemical impairment detection system and method of use to reduce circumvention |
11/26/2009 | WO2009143519A2 Biomarkers for myocardial ischemia |
11/26/2009 | WO2009143512A2 Compositions and methods relating to detection of soluble e-cadherin in neurodegenerative disease |
11/26/2009 | WO2009143493A2 MODULATORS OF TNFα-DEPENDENT SIGNALING PATHWAYS AND USES THEREOF |
11/26/2009 | WO2009143468A1 Tumor suppressor-based susceptibility of hyperproliferative cells to oncolytic viral therapy |
11/26/2009 | WO2009143447A1 Multivariable process fluid flow device with energy flow calculation |
11/26/2009 | WO2009143373A1 Detection of peroxide radicals and reaction initiators |
11/26/2009 | WO2009143367A2 Egf-a domain-mediated modulation of pcsk9 |
11/26/2009 | WO2009143365A2 Compositions and methods of treatment using modulators of motoneuron diseases |
11/26/2009 | WO2009143238A1 A process for determining the distillation characteristics of a liquid petroleum product containing an azeotropic mixture |
11/26/2009 | WO2009143212A1 Computer system and computer-facilitated method for nucleic acid sequence alignment and analysis |
11/26/2009 | WO2009143168A2 Vaccine assays |
11/26/2009 | WO2009143149A2 Improved imaging of immunomagnetically enriched rare cells |
11/26/2009 | WO2009143133A2 Compositions and methods to protect cells by blocking entry of pathogen proteins |
11/26/2009 | WO2009143098A2 Isolated human autoantibodies to natriuretic peptides and methods and kits for detecting human autoantibodies to natriuretic peptides |
11/26/2009 | WO2009143083A2 Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm |
11/26/2009 | WO2009143081A2 Methods, devices kits and compositions for detecting roundworm |
11/26/2009 | WO2009143080A2 Methods, devices, kits and compositions for detecting roundworm |
11/26/2009 | WO2009143079A2 Methods, devices, kits and compositions for detecting roundworm |
11/26/2009 | WO2009143067A2 Methods, devices, kits and compositions for detecting whipworm |
11/26/2009 | WO2009143014A1 Glp-1 receptor agonist bioassays |
11/26/2009 | WO2009142888A2 Immortal unipotent porcine picm- 19h and picm- 19b stem cell lines |
11/26/2009 | WO2009142835A2 Method and apparatus for analyzing skin and hair |
11/26/2009 | WO2009142744A2 Predicting hemostatic risk; dependence on plasma composition |
11/26/2009 | WO2009142743A1 Methods, systems and devices for analyzing a surfactant-treated biological fluid sample |
11/26/2009 | WO2009142742A1 Methods, systems and devices for analyzing a biological fluid sample following ion exchange |
11/26/2009 | WO2009142735A2 LUCIFERASE BIOSENSORS FOR cAMP |
11/26/2009 | WO2009142724A2 Novel gpr101 transgenic mice and methods of use thereof |
11/26/2009 | WO2009142678A1 Protein labeling with cyanobenzothiazole conjugates |
11/26/2009 | WO2009142638A1 Protein assay |
11/26/2009 | WO2009142604A1 Polymer encapsulated particles as surface enhanced raman scattering probes |
11/26/2009 | WO2009142313A1 Method for searching for gene encoding protein targeted by compound |
11/26/2009 | WO2009142303A1 Method for evaluation of function of phagocyte |
11/26/2009 | WO2009142271A1 Cancer stem cell having high level of sld5 expression therein |
11/26/2009 | WO2009142268A1 Method for evaluation of the state of skin barrier function by natural moisturizing factor of employing the activity of bleomycin hydrolase as measure |
11/26/2009 | WO2009142257A1 Composition and method for determination of esophageal cancer |
11/26/2009 | WO2009142214A1 Rna in situ hybridization |
11/26/2009 | WO2009142086A1 Vaccine composition for mycoplasma infection |
11/26/2009 | WO2009142045A1 Piezoelectric sensor and sensing device |
11/26/2009 | WO2009141926A1 Method for acquisition of compound capable of acting on glucose metabolism/lipid metabolism |
11/26/2009 | WO2009141679A2 Ceacam1 based point-of-care cancer diagnostic |
11/26/2009 | WO2009141661A1 Total plasma fvi i /fvi ia levels as indicators of pre-eclampsia of pregnant females |
11/26/2009 | WO2009141637A1 A sensor |
11/26/2009 | WO2009141628A1 Method of testing for antiphospholipid antibodies |
11/26/2009 | WO2009141619A1 Methods of distinguishing between glutamine formed by cataplerosis or proteolysis |
11/26/2009 | WO2009141458A1 Antibody specific for propionylated/butyrylated lysine, method for obtaining same and uses thereof |
11/26/2009 | WO2009141441A1 Inhibition of the nt-3:trkc bound and its application to the treatment of cancer such as neuroblastoma |
11/26/2009 | WO2009141374A1 L-fabp, natriuretic peptides and cardiac troponin in individuals in need for a cardiac therapy |
11/26/2009 | WO2009141359A1 New biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof |
11/26/2009 | WO2009141357A1 Gdf-15 as biomarker in type 1 diabetes |
11/26/2009 | WO2009141352A2 Risk analysis in patients with and without metabolic syndrome |
11/26/2009 | WO2009141310A1 Mass spectrometric analysis |
11/26/2009 | WO2009141301A1 Method for determining the dna repair capacity of a cell |
11/26/2009 | WO2009141180A1 Triple function electrodes |
11/26/2009 | WO2009141141A1 Method for high throughput peptide/protein assay generation and assays generated therewith |
11/26/2009 | WO2009141135A1 Method and device for a high precision measurement of a characteristic of a fouling and/or scaling deposit inside a fluid vessel or of a characteristic of a portion of the wall inside a fluid vessel by using an ultrsonic transducer |
11/26/2009 | WO2009141121A1 Method for rapid generation of phosphorylation profiles, the detection of in vivo phosphorylation sites of kinases and phosphatases and their use as diagnostic markers in cells, tissues and body fluids |
11/26/2009 | WO2009141087A1 Device and method for detecting trace gases |
11/26/2009 | WO2009140876A1 Integration methods of enriching and detecting rare cells from biological body fluids samples |
11/26/2009 | WO2009140826A1 A reagent kit package for measuring oxidative stress period of organism and its use |
11/26/2009 | WO2009140805A1 A method for increasing the veracity of classification in the sample and thereof kit |
11/26/2009 | WO2009140796A1 A particle concentration measuring device and method |
11/26/2009 | WO2009140763A1 Novel ghrelin analogues |
11/26/2009 | WO2009140757A1 Device and method for fluorescence-based imaging and monitoring |
11/26/2009 | WO2009140754A1 An anti-cancer cytotoxic monoclonal antibody |
11/26/2009 | WO2009140735A1 Analyte detection by microneedle patch with analyte selective reagents. |
11/26/2009 | WO2009140724A1 Herg mutants and uses thereof |
11/26/2009 | WO2009140715A1 Diagnostic method |
11/26/2009 | WO2009122368A3 Biomarker assay and method of use thereof |
11/26/2009 | WO2009122367A3 Procollagen c-proteinase enhancer (pcpe) biomarker for bone formation |
11/26/2009 | WO2009119993A3 Immunochromatography kit and manufacturing method thereof |
11/26/2009 | WO2009118204A3 Medicament, compositions, and substances for treating and identifying adenocarcinoma of the lung |
11/26/2009 | WO2009116861A3 Diagnostic of pre-symptomatic metabolic syndrome |
11/26/2009 | WO2009114709A3 Detection of polymeric analytes |
11/26/2009 | WO2009112702A3 Method for in vitro detection and/or quantification and/or identification of bacteria in a biological material |
11/26/2009 | WO2009111316A3 Barriers for facilitating biological reactions |
11/26/2009 | WO2009111254A3 A rapid and sensitive method for quantitative determination of the level of heparin-pf4 complex induced immunoglobulin antibodies |
11/26/2009 | WO2009108826A3 System and method for data analysis and capture |
11/26/2009 | WO2009108716A3 Synthetic peptides |
11/26/2009 | WO2009108687A3 Device and system to reconstruct travel history of an individual |
11/26/2009 | WO2009108239A3 Slope-based compensation |
11/26/2009 | WO2009107988A3 Apparatus and method for analyzing urine components in toilet in real-time by using miniature atr infrared spectroscopy |
11/26/2009 | WO2009106065A3 Biomarker for the diagnosis of a brain tumor |
11/26/2009 | WO2009105757A3 Methods and compositions for diagnosis of age-related macular degeneration |
11/26/2009 | WO2009105670A3 Substrates for multiplexed assays and uses thereof |
11/26/2009 | WO2009105591A3 Methods and systems for genome-scale kinetic modeling |
11/26/2009 | WO2009105537A3 Non-invasive optical characterization of biomaterial mineralization |
11/26/2009 | WO2009105533A3 Methods for predicting esophageal adenocarcinoma (eac) |
11/26/2009 | WO2009105520A3 Methods, devices, and compositions for the highly-sensitive detection and identification of diverse molecular entities |
11/26/2009 | WO2009104974A3 Biomarkers for acute coronary disorder |
11/26/2009 | WO2009104890A3 Polymicrobial detection device using quantum dot nanocrystal complexes and a detection method therefor |
11/26/2009 | WO2009102632A3 Method for isolating cell free apoptotic or fetal nucleic acids |
11/26/2009 | WO2009102470A3 Compositions and methods for use in analytical reactions |
11/26/2009 | WO2009102469A3 Regulation of cyclin d |
11/26/2009 | WO2009102446A3 Fish assay for eml4 and alk fusion in lung cancer |
11/26/2009 | WO2009098196A3 Molecular targets and compounds, methods to identify the same, useful in the treatment of neurodegenerative diseases. |
11/26/2009 | WO2009086478A3 Stimulated emission and enhanced detection of chemicals and chemical compounds |
11/26/2009 | WO2009082417A3 Immobilizing an entity in a desired orientation on a support material |